Diana F. Lazaro

Robert Koch Str. 40
Goettingen, NI 37075, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Synphilin-1 modulates alpha-synuclein assembly, release and uptake.

Synphilin-1 modulates alpha-synuclein assembly, release and uptake.

Journal: NPJ Parkinson's disease

Published: March 03, 2025

Navigating through the complexities of synucleinopathies: Insights into pathogenesis, heterogeneity, and future perspectives.

Navigating through the complexities of synucleinopathies: Insights into pathogenesis, heterogeneity, and future perspectives.

Journal: Neuron

Published: January 18, 2024

Alpha-synuclein overexpression induces epigenomic dysregulation of glutamate signaling and locomotor pathways.

Alpha-synuclein overexpression induces epigenomic dysregulation of glutamate signaling and locomotor pathways.

Journal: Human molecular genetics

Published: October 08, 2021

In silico analysis of the aggregation propensity of the SARS-CoV-2 proteome: Insight into possible cellular pathologies.

In silico analysis of the aggregation propensity of the SARS-CoV-2 proteome: Insight into possible cellular pathologies.

Journal: Biochimica et biophysica acta. Proteins and proteomics

Published: May 25, 2021

Identification of Two Novel Peptides That Inhibit α-Synuclein Toxicity and Aggregation.

Identification of Two Novel Peptides That Inhibit α-Synuclein Toxicity and Aggregation.

Journal: Frontiers in molecular neuroscience

Published: January 28, 2021

Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo.

Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo.

Journal: Neurobiology of disease

Published: November 16, 2020

DEAD-box RNA helicase Dbp4/DDX10 is an enhancer of α-synuclein toxicity and oligomerization.

DEAD-box RNA helicase Dbp4/DDX10 is an enhancer of α-synuclein toxicity and oligomerization.

Journal: PLoS genetics

Published: July 15, 2020

X1INH, an improved next-generation affinity-optimized hydrazonic ligand, attenuates abnormal copper(I)/copper(II)-α-Syn interactions and affects protein aggregation in a cellular model of synucleinopathy.

X1INH, an improved next-generation affinity-optimized hydrazonic ligand, attenuates abnormal copper(I)/copper(II)-α-Syn interactions and affects protein aggregation in a cellular model of synucleinopathy.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: May 12, 2020

The Interplay Between Proteostasis Systems and Parkinson's Disease.

The Interplay Between Proteostasis Systems and Parkinson's Disease.

Journal: Advances in experimental medicine and biology

Published: April 11, 2020

Editorial: Protein Misfolding and Spreading Pathology in Neurodegenerative Diseases.

Editorial: Protein Misfolding and Spreading Pathology in Neurodegenerative Diseases.

Journal: Frontiers in molecular neuroscience

Published: November 17, 2019

Synucleinopathies: Where we are and where we need to go.

Synucleinopathies: Where we are and where we need to go.

Journal: Journal of neurochemistry

Published: November 07, 2019

Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies.

Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies.

Journal: Biochimica et biophysica acta. Proteins and proteomics

Published: July 04, 2019

Showing 1-12 of 31

Last Updated: 09/26/2026